MANILA-- The Philippines has 361 COVID-19 patients enrolled in the World Health Organization’s multi-country Solidarity Trial in search for treatment of the infectious disease, President Rodrigo Duterte said in his report to Congress on Monday.
The patients are from 26 different hospitals, the President said.
A P29.99 million budget has been approved for the one-year project.
The Solidarity Trial involves the participation of more than 100 countries who want to help test four drug and drug combinations that are believed to help treat COVID-19 patients.
These are remdesivir, lopinavir and ritonavir combined, lopinavir and ritonavir plus interferon beta, and hydroxychloroquine.
These are all off-label drugs, which means they were created for other illnesses but are believed to have a positive effect on coronavirus patients.
In April, the Philippines said it will enroll an initial 500 patients in the multi-country clinical trials. Informed consent is required for all clinical studies.
As of June 29, the Philippines has confirmed 36,438 COVID-19 cases. This includes 1,255 deaths and 9,956 recoveries.